This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2004.
Company Filing History:
1 out of 834,411 Years Active: 2004
Title: Junliang Pan: Innovator in Chemokine Modulation
Introduction
Junliang Pan is a notable inventor based in El Cerrito, California. He has made significant contributions to the field of chemokine research, particularly in understanding the interactions between MEC and CCR3/CCR10. His innovative work has the potential to impact therapeutic approaches for inflammatory conditions.
Latest Patents
Junliang Pan holds a patent titled "Method for identifying agents which modulate chemokine 'MEC'-induced functions of CCR3." This invention focuses on the interaction of MEC with CCR3 and/or CCR10, as well as agents that can alter this interaction. The patent outlines methods for detecting or identifying agents that can modulate the binding of MEC to these receptors. Additionally, it describes a method for treating subjects with inflammatory conditions by administering agents that influence this binding.
Career Highlights
Throughout his career, Junliang Pan has demonstrated a commitment to advancing scientific knowledge in the field of immunology. His work has led to the development of innovative methods that could enhance the understanding and treatment of inflammatory diseases. With 1 patent to his name, he continues to contribute to the scientific community.
Collaborations
Junliang Pan has collaborated with esteemed colleagues such as Eugene C Butcher and Eric J Kunkel. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.
Conclusion
Junliang Pan's contributions to chemokine modulation represent a significant advancement in the field of immunology. His innovative patent work has the potential to lead to new therapeutic strategies for treating inflammatory conditions.